104 related articles for article (PubMed ID: 20593489)
1. Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B.
Sun L; Gao J; Huo L; Sun X; Shi X; Liu M; Li D; Zhang C; Zhou J
J Pathol; 2010 Aug; 221(4):425-32. PubMed ID: 20593489
[TBL] [Abstract][Full Text] [Related]
2. The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.
Saito K; Kigawa T; Koshiba S; Sato K; Matsuo Y; Sakamoto A; Takagi T; Shirouzu M; Yabuki T; Nunokawa E; Seki E; Matsuda T; Aoki M; Miyata Y; Hirakawa N; Inoue M; Terada T; Nagase T; Kikuno R; Nakayama M; Ohara O; Tanaka A; Yokoyama S
Structure; 2004 Sep; 12(9):1719-28. PubMed ID: 15341735
[TBL] [Abstract][Full Text] [Related]
3. Phosphoregulation of MgcRacGAP in mitosis involves Aurora B and Cdk1 protein kinases and the PP2A phosphatase.
Touré A; Mzali R; Liot C; Seguin L; Morin L; Crouin C; Chen-Yang I; Tsay YG; Dorseuil O; Gacon G; Bertoglio J
FEBS Lett; 2008 Apr; 582(8):1182-8. PubMed ID: 18201571
[TBL] [Abstract][Full Text] [Related]
4. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.
Rong R; Jiang LY; Sheikh MS; Huang Y
Oncogene; 2007 Dec; 26(55):7700-8. PubMed ID: 17563743
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
6. Aurora B-mediated phosphorylation of RASSF1A maintains proper cytokinesis by recruiting Syntaxin16 to the midzone and midbody.
Song SJ; Kim SJ; Song MS; Lim DS
Cancer Res; 2009 Nov; 69(22):8540-4. PubMed ID: 19887622
[TBL] [Abstract][Full Text] [Related]
7. RASSF1A interacts with and activates the mitotic kinase Aurora-A.
Liu L; Guo C; Dammann R; Tommasi S; Pfeifer GP
Oncogene; 2008 Oct; 27(47):6175-86. PubMed ID: 18641684
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity.
Ishikawa Y; Tsunoda K; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Int J Oncol; 2012 Jul; 41(1):53-60. PubMed ID: 22469839
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of Cdc2 and Aurora-A in Xenopus oocytes: a crucial role of phosphatase 2A.
Maton G; Lorca T; Girault JA; Ozon R; Jessus C
J Cell Sci; 2005 Jun; 118(Pt 11):2485-94. PubMed ID: 15923661
[TBL] [Abstract][Full Text] [Related]
10. EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A.
Sun L; Gao J; Dong X; Liu M; Li D; Shi X; Dong JT; Lu X; Liu C; Zhou J
Proc Natl Acad Sci U S A; 2008 May; 105(20):7153-8. PubMed ID: 18477699
[TBL] [Abstract][Full Text] [Related]
11. Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM).
Yokoyama T; Goto H; Izawa I; Mizutani H; Inagaki M
Genes Cells; 2005 Feb; 10(2):127-37. PubMed ID: 15676024
[TBL] [Abstract][Full Text] [Related]
12. CYLD mutations in familial skin appendage tumours.
Saggar S; Chernoff KA; Lodha S; Horev L; Kohl S; Honjo RS; Brandt HR; Hartmann K; Celebi JT
J Med Genet; 2008 May; 45(5):298-302. PubMed ID: 18234730
[TBL] [Abstract][Full Text] [Related]
13. Aurora-B associated protein phosphatases as negative regulators of kinase activation.
Sugiyama K; Sugiura K; Hara T; Sugimoto K; Shima H; Honda K; Furukawa K; Yamashita S; Urano T
Oncogene; 2002 May; 21(20):3103-11. PubMed ID: 12082625
[TBL] [Abstract][Full Text] [Related]
14. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
[TBL] [Abstract][Full Text] [Related]
15. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.
Song SJ; Song MS; Kim SJ; Kim SY; Kwon SH; Kim JG; Calvisi DF; Kang D; Lim DS
Cancer Res; 2009 Mar; 69(6):2314-23. PubMed ID: 19276349
[TBL] [Abstract][Full Text] [Related]
16. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
Katayama H; Sasai K; Czerniak BA; Carter JL; Sen S
J Cell Biochem; 2007 Dec; 102(5):1318-31. PubMed ID: 17957726
[TBL] [Abstract][Full Text] [Related]
17. An emerging role of deubiquitinating enzyme cylindromatosis (CYLD) in the tubulointerstitial inflammation of IgA nephropathy.
Cui TG; Ichikawa T; Yang M; Dong X; Li J; Cui T
Biochem Biophys Res Commun; 2009 Dec; 390(2):307-12. PubMed ID: 19800320
[TBL] [Abstract][Full Text] [Related]
18. Aurora-a contributes to radioresistance by increasing NF-kappaB DNA binding.
Oh ET; Byun MS; Lee H; Park MT; Jue DM; Lee CW; Lim BU; Park HJ
Radiat Res; 2010 Sep; 174(3):265-73. PubMed ID: 20726719
[TBL] [Abstract][Full Text] [Related]
19. MST1 limits the kinase activity of aurora B to promote stable kinetochore-microtubule attachment.
Oh HJ; Kim MJ; Song SJ; Kim T; Lee D; Kwon SH; Choi EJ; Lim DS
Curr Biol; 2010 Mar; 20(5):416-22. PubMed ID: 20171103
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of an Aurora-C kinase-deficient mutant disrupts the Aurora-B/INCENP complex and induces polyploidy.
Chen HL; Tang CJ; Chen CY; Tang TK
J Biomed Sci; 2005; 12(2):297-310. PubMed ID: 15917996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
